Role of aldosterone in experimental hypertension. - Suppr | 超能文献

Role of aldosterone in experimental hypertension.

作者信息

McCaa R E, McCaa C S, Bengis R G, Guyton A C

出版信息

J Endocrinol. 1979 May;81(2):69P-78P.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Role of aldosterone in experimental hypertension.

J Endocrinol. 1979 May;81(2):69P-78P.

2

[Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].

Nihon Jinzo Gakkai Shi. 1980 Jan;22(1):13-22.

3

Role of the renin-angiotensin-aldosterone system in the regulation of blood pressure.

Adv Nephrol Necker Hosp. 1980;9:271-93.

4

[Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension].[口服血管紧张素I转换酶抑制剂对两例急性肾血管性高血压患者肾切除术前、后血压及肾素-血管紧张素-醛固酮系统的影响]

Nihon Jinzo Gakkai Shi. 1982 Sep;24(9):1029-39.

5

[Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].[使用SQ - 14225（卡托普利）抑制血管紧张素I转换酶治疗重度肾血管性高血压]

Rev Clin Esp. 1981 Sep 30;162(6):265-8.

6

Effects of angiotensin antagonists in various forms of experimental arterial hypertension.血管紧张素拮抗剂在各种形式实验性动脉高血压中的作用。

Prog Biochem Pharmacol. 1976;12:86-97.

7

Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.卡托普利和依那普利对缺钠犬钠排泄及血压的影响。

Fed Proc. 1984 Apr;43(5):1336-41.

8

Renin-angiotensin system in an infant with malignant renovascular hypertension.一名患有恶性肾血管性高血压婴儿的肾素-血管紧张素系统

Helv Paediatr Acta. 1976 Jun;31(1):61-5.

9

Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.患有与慢性肾病相关高血压的猫的血浆肾素活性、血管紧张素I和醛固酮浓度

Am J Vet Res. 1997 May;58(5):535-40.

10

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.一种用于识别和治疗高血压患者血管收缩和容量因素的血管紧张素转换酶抑制剂。

N Engl J Med. 1974 Oct 17;291(16):817-21. doi: 10.1056/NEJM197410172911603.

引用本文的文献

1

Combined antihypertensive effect of unripe Rubus coreanus Miq. and Dendropanax morbiferus H. Lév. Extracts in 1 kidney-1 clip hypertensive rats and spontaneously hypertensive rats.未成熟悬钩子和杠柳提取物对 1 肾 1 夹高血压大鼠和自发性高血压大鼠的联合降压作用。

BMC Complement Med Ther. 2021 Oct 28;21(1):271. doi: 10.1186/s12906-021-03438-4.

2

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.卡托普利：对其药理特性和治疗效果的初步综述。

Drugs. 1980 Dec;20(6):409-52. doi: 10.2165/00003495-198020060-00001.

3

Effects of SQ 14.225, an orally active inhibitor of angiotensin-converting enzyme, on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.口服活性血管紧张素转换酶抑制剂SQ 14.225对大鼠低氧性肺动脉高压和右心室肥厚的影响

Basic Res Cardiol. 1981 May-Jun;76(3):344-51. doi: 10.1007/BF01907777.

4

Involvement of the renin-angiotensin system in captopril-induced sodium appetite in the rat.肾素-血管紧张素系统在卡托普利诱导大鼠钠食欲中的作用。

J Physiol. 1984 Sep;354:11-27. doi: 10.1113/jphysiol.1984.sp015359.